{"parse":{"title":"Pharmaceutical Affairs Act (Japan)","pageid":32550249,"revid":831732168,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>Pharmaceutical Affairs Law</b> or <b>Pharmaceutical Affairs Act</b><span style=\"font-weight: normal\">&#32;(<span lang=\"ja\">\u85ac\u4e8b\u6cd5</span><span style=\"display:none\">,</span>&#32;<i>Yakujih\u014d</i>)</span> of <a href=\"/wiki/Japan\" title=\"Japan\">Japan</a> is a law regulating the manufacturing, importation, and sale of drugs and medical devices. It was originally passed in 1960.<sup id=\"cite_ref-Nomura_1-0\" class=\"reference\"><a href=\"#cite_note-Nomura-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Legislative_history\">Legislative history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmaceutical_Affairs_Act_(Japan)&amp;action=edit&amp;section=1\" title=\"Edit section: Legislative history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The July 2002 amendment to the law changed the regulatory structure for pharmaceuticals and medical devices, in an effort to align laws more closely with those in the European Union, Australia, Canada, and the United States. The amendment shifted the focus of regulation from the point of manufacturing to the <a href=\"/wiki/Point_of_sale\" title=\"Point of sale\">point of sale</a>, and adopted a risk-based classification system for products.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p><p>The June 2006 amendment to the law (Law No. 69 of 2006, with effective date of June 2009), represented the first change in the sales structure of OTC drugs in 46 years.<sup id=\"cite_ref-Nomura_1-1\" class=\"reference\"><a href=\"#cite_note-Nomura-1\">&#91;1&#93;</a></sup> The amended law permitted stores to sell certain <a href=\"/wiki/Over-the-counter_drugs\" class=\"mw-redirect\" title=\"Over-the-counter drugs\">over-the-counter drugs</a> without having a pharmacist on staff, opening up the market to <a href=\"/wiki/Convenience_store\" title=\"Convenience store\">convenience stores</a>, <a href=\"/wiki/Supermarkets\" class=\"mw-redirect\" title=\"Supermarkets\">supermarkets</a>, and other such stores. <a href=\"/wiki/7-Eleven\" title=\"7-Eleven\">7-Eleven</a> was the first convenience store to take advantage of the amended law, while <a href=\"/wiki/%C3%86on_(company)\" class=\"mw-redirect\" title=\"\u00c6on (company)\">Aeon</a> supermarkets also began selling OTC drugs at a 20% to 40% discount to competing drug stores (including Aeon-affiliated companies). The amendment was expected to put significant competitive pressure on drug stores. However, the law continued to ban internet sales of OTC drugs, which the Ministry of Health had previously justified by stating that drug sales should only be conducted in person by pharmacists or other qualified vendors who could explain the <a href=\"/wiki/Side_effect\" title=\"Side effect\">side effects</a> of the drugs.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>On May 24, 2013, the Government Cabinet approved a revision of Pharmaceutical Affairs Law to simplify the approval process for medical devices and regenerative medicine products, the safety of regenerative medicine using iPS cells (stem cells).\n</p><p>According to the revised bill, medical equipment can be checked by the private organization including regenerative medicine products and validation of the post-marketing effectiveness.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmaceutical_Affairs_Act_(Japan)&amp;action=edit&amp;section=2\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Nomura-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Nomura_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Nomura_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFMatsuo2009\" class=\"citation\">Matsuo, Daisuke (December 2009), <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nri.co.jp/english/opinion/papers/2009/pdf/np2009149.pdf\">\"Effect of Amendment to Japan's Pharmaceutical Affairs Law\"</a> <span style=\"font-size:85%;\">(PDF)</span>, <i>Nomura Research Institute Papers</i> (149)<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">2011-07-26</span></span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nomura+Research+Institute+Papers&amp;rft.atitle=Effect+of+Amendment+to+Japan%27s+Pharmaceutical+Affairs+Law&amp;rft.issue=149&amp;rft.date=2009-12&amp;rft.aulast=Matsuo&amp;rft.aufirst=Daisuke&amp;rft_id=http%3A%2F%2Fwww.nri.co.jp%2Fenglish%2Fopinion%2Fpapers%2F2009%2Fpdf%2Fnp2009149.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmaceutical+Affairs+Act+%28Japan%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFD&#39;Eramo2007\" class=\"citation\">D'Eramo, Paul (February 2007), <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ispe.org/cs/regulatory_review_archive/february_2007_japans_pharmaceutical_affairs_law_pal_opportunities_and_challenges\">\"Japan's Pharmaceutical Affairs Law (PAL): Opportunities and Challenges\"</a>, <i>Regulatory Review of the International Society for Pharmaceutical Engineering</i><span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">2011-07-26</span></span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Regulatory+Review+of+the+International+Society+for+Pharmaceutical+Engineering&amp;rft.atitle=Japan%27s+Pharmaceutical+Affairs+Law+%28PAL%29%3A+Opportunities+and+Challenges&amp;rft.date=2007-02&amp;rft.aulast=D%27Eramo&amp;rft.aufirst=Paul&amp;rft_id=http%3A%2F%2Fwww.ispe.org%2Fcs%2Fregulatory_review_archive%2Ffebruary_2007_japans_pharmaceutical_affairs_law_pal_opportunities_and_challenges&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmaceutical+Affairs+Act+%28Japan%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\">\n<cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"http://search.japantimes.co.jp/cgi-bin/nn20090602a3.html\">\"Convenience stores start sales of OTC drugs\"</a>, <i>Japan Times</i>, 2009-06-02<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">2011-07-26</span></span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Japan+Times&amp;rft.atitle=Convenience+stores+start+sales+of+OTC+drugs&amp;rft.date=2009-06-02&amp;rft_id=http%3A%2F%2Fsearch.japantimes.co.jp%2Fcgi-bin%2Fnn20090602a3.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmaceutical+Affairs+Act+%28Japan%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.asahi.com/politics/update/0524/TKY201305240029.html\">http://www.asahi.com/politics/update/0524/TKY201305240029.html</a></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmaceutical_Affairs_Act_(Japan)&amp;action=edit&amp;section=3\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://law.e-gov.go.jp/cgi-bin/idxselect.cgi?IDX_OPT=1&amp;H_NAME=%96%f2%8e%96%96%40&amp;H_NAME_YOMI=%82%a0&amp;H_NO_GENGO=H&amp;H_NO_YEAR=&amp;H_NO_TYPE=2&amp;H_NO_NO=&amp;H_FILE_NAME=S35HO145&amp;H_RYAKU=1&amp;H_CTG=1&amp;H_YOMI_GUN=1&amp;H_CTG_GUN=1\">Full text of the law</a><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since March 2018\">permanent dead link</span></a></i>&#93;</span></sup></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q7180723&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q7180723&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q7180723\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"><a href=\"/wiki/National_Diet_Library\" title=\"National Diet Library\">NDL</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://id.ndl.go.jp/auth/ndlna/00574217\">00574217</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2236\nCached time: 20180921150842\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.116 seconds\nReal time usage: 0.162 seconds\nPreprocessor visited node count: 510/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 13936/2097152 bytes\nTemplate argument size: 1106/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4235/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.060/10.000 seconds\nLua memory usage: 2.64 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  145.822      1 -total\n 38.49%   56.130      1 Template:Reflist\n 28.27%   41.217      3 Template:Citation\n 26.80%   39.079      1 Template:Authority_control\n 23.93%   34.891      1 Template:Nihongo\n 22.96%   33.484      3 Template:Category_handler\n  8.23%   12.000      1 Template:Dead_link\n  5.51%    8.035      1 Template:Fix\n  1.77%    2.588      1 Template:Fix/category\n  1.65%    2.403      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:32550249-0!canonical and timestamp 20180921150841 and revision id 831732168\n -->\n</div>"},"langlinks":[{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E5%8C%BB%E8%96%AC%E5%93%81%E3%80%81%E5%8C%BB%E7%99%82%E6%A9%9F%E5%99%A8%E7%AD%89%E3%81%AE%E5%93%81%E8%B3%AA%E3%80%81%E6%9C%89%E5%8A%B9%E6%80%A7%E5%8F%8A%E3%81%B3%E5%AE%89%E5%85%A8%E6%80%A7%E3%81%AE%E7%A2%BA%E4%BF%9D%E7%AD%89%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E6%B3%95%E5%BE%8B","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u7b49\u306e\u54c1\u8cea\u3001\u6709\u52b9\u6027\u53ca\u3073\u5b89\u5168\u6027\u306e\u78ba\u4fdd\u7b49\u306b\u95a2\u3059\u308b\u6cd5\u5f8b"}],"categories":[{"sortkey":"","hidden":"","*":"Articles_containing_Japanese-language_text"},{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_March_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_NDL_identifiers"},{"sortkey":"","*":"1960_in_law"},{"sortkey":"","*":"Drug_control_law"},{"sortkey":"","*":"Japanese_legislation"},{"sortkey":"","*":"Medical_law"},{"sortkey":"","*":"Drugs_in_Japan"},{"sortkey":"","*":"Regulation_of_medical_devices"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with dead external links from March 2018"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with NDL identifiers"},{"ns":0,"exists":"","*":"7-Eleven"},{"ns":0,"exists":"","*":"Convenience store"},{"ns":0,"exists":"","*":"Japan"},{"ns":0,"exists":"","*":"National Diet Library"},{"ns":0,"exists":"","*":"Over-the-counter drugs"},{"ns":0,"exists":"","*":"Point of sale"},{"ns":0,"exists":"","*":"Side effect"},{"ns":0,"exists":"","*":"Supermarkets"},{"ns":0,"exists":"","*":"\u00c6on (company)"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":12,"exists":"","*":"Help:Authority control"}],"templates":[{"ns":10,"exists":"","*":"Template:Nihongo"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"}],"images":["Blue_pencil.svg"],"externallinks":["http://www.nri.co.jp/english/opinion/papers/2009/pdf/np2009149.pdf","http://www.ispe.org/cs/regulatory_review_archive/february_2007_japans_pharmaceutical_affairs_law_pal_opportunities_and_challenges","http://search.japantimes.co.jp/cgi-bin/nn20090602a3.html","http://www.asahi.com/politics/update/0524/TKY201305240029.html","https://www.wikidata.org/wiki/Q7180723","http://law.e-gov.go.jp/cgi-bin/idxselect.cgi?IDX_OPT=1&H_NAME=%96%F2%8E%96%96@&H_NAME_YOMI=%82%A0&H_NO_GENGO=H&H_NO_YEAR=&H_NO_TYPE=2&H_NO_NO=&H_FILE_NAME=S35HO145&H_RYAKU=1&H_CTG=1&H_YOMI_GUN=1&H_CTG_GUN=1","https://id.ndl.go.jp/auth/ndlna/00574217"],"sections":[{"toclevel":1,"level":"2","line":"Legislative history","number":"1","index":"1","fromtitle":"Pharmaceutical_Affairs_Act_(Japan)","byteoffset":527,"anchor":"Legislative_history"},{"toclevel":1,"level":"2","line":"References","number":"2","index":"2","fromtitle":"Pharmaceutical_Affairs_Act_(Japan)","byteoffset":3025,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"3","index":"3","fromtitle":"Pharmaceutical_Affairs_Act_(Japan)","byteoffset":3055,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pharmaceutical Affairs Act (Japan)","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q7180723"}]}}